Opinion: The 4 arguments you will hear against drug price negotiation

, September 6, 2023
Pharma

Here are some of the arguments you're likely to hear against drug price negotiation and the context necessary to evaluate them.

Judge withdraws from Medicare drug price case after stock ownership is revealed

, September 5, 2023
Pharma

A federal judge on Friday withdrew from a case that could block Medicare from negotiating over drug prices, just hours after a watchdog group revealed his ownership of stock in two pharmaceutical companies.

Biden administration expects to win fight over Medicare drug negotiations

, September 5, 2023
Pharma

White House domestic policy adviser Neera Tanden says she's convinced that the Inflation Reduction Act's Medicare drug price negotiation program will be upheld in court.

J&J's $40B split-off sets stage for pharma, medical tech expansion 

, September 5, 2023
Pharma

The healthcare giant's separation of its consumer-health business arms it with billions in cash for allocating capital in the remaining businesses.

FTC allows Amgen to move forward with $27.8B Horizon Therapeutics acquisition

, September 1, 2023
Pharma

The FTC on Friday said it has reached a deal with drug giant Amgen to allow the company's $27.8 billion purchase of Horizon Therapeutics to move forward. 

J&J cuts the price of its lifesaving TB pill by more than half for many low- and middle-income countries

, August 31, 2023
Pharma

Advocacy groups continue to argue that Johnson & Johnson, which makes the pill, has stymied wider access.

Pages